Shuhei Nakanishi

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

Medicine, Pharmacology, Pharmacotherapy +15

Decreased Total and High Molecular Weight Adiponectin Are Independent Risk Factors for the Development of Type 2 Diabetes in Japanese-Americans

Reiko Nakashima, Nozomu Kamei, Kiminori Yamane et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 158 citations · Full text

Medicine, Biochemistry, Endocrinology +12

Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening

Nozomu Kamei, Kiminori Yamane, Shuhei Nakanishi et al. · Journal of Diabetes and its Complications · 2005 · 152 citations

Medicine, Neurology, Preventive Medicine +12

Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans

Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei et al. · Diabetes Care · 2003 · 148 citations

Medicine, Endocrinology, Health Sciences +8

A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane

Shuhei Nakanishi, Kiminori Yamane, Nozomu Kamei et al. · Metabolism · 2005 · 114 citations

Life Sciences, Biochemistry, Endocrinology +12